RITSUKO KOMAKI to Receptors, Tumor Necrosis Factor, Type I
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Receptors, Tumor Necrosis Factor, Type I.
Connection Strength
0.022
-
Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun. 2010 Aug; 24(6):968-74.
Score: 0.022